Introduction
Medicines are essential components of modern healthcare, but not every available medicine is equally necessary, appropriate or accessible. Essential medicine policies aim to ensure that priority health needs can be met through medicines that are selected according to public health relevance, evidence of efficacy and safety, and comparative cost-effectiveness. Rational drug selection applies these principles to individual clinical situations while considering the characteristics and needs of the patient.
Essential medicines
Definition
Essential medicines are medicines that satisfy the priority healthcare needs of a population. They are intended to be available within functioning health systems in appropriate dosage forms, assured quality and at prices individuals and communities can afford.
Who essential medicines concept
The World Health Organization maintains a Model List of Essential Medicines that supports countries in developing or updating their own national essential medicines lists.
Core principles
Selection based on public health relevance.
Evidence of efficacy and safety.
Comparative cost-effectiveness.
Appropriate dosage forms and strengths.
Assured quality.
Reliable availability within healthcare systems.
Selection criteria
| Criterion | Explanation |
|---|---|
Public health relevance | The medicine should address an important health need or disease burden. |
Efficacy | Reliable evidence should demonstrate that the medicine produces the intended beneficial effects. |
Safety | Potential risks and adverse effects should be evaluated in relation to expected benefits. |
Comparative cost-effectiveness | The medicine should be assessed in relation to suitable alternatives and the resources required. |
Quality | The product should meet appropriate pharmaceutical quality standards. |
Availability | The medicine should be suitable for reliable procurement, storage and distribution. |
Appropriate formulation | Dosage forms and strengths should meet the needs of relevant patient populations and healthcare settings. |
Essential medicines lists
International level
The WHO Model List provides an evidence-informed reference for national selection and policy development.
National level
Countries adapt essential medicine selection to their healthcare priorities, disease patterns, resources and regulatory systems.
Institutional level
Hospitals and healthcare organizations may maintain formularies to guide medicine procurement and use.
Important limitation
Being included on an essential medicines list does not mean that a medicine is appropriate for every patient or every clinical situation. Individual treatment decisions still require clinical assessment.
Rational drug selection
Definition
Rational drug selection is the process of choosing a medicine that is appropriate for a patient's clinical condition, supported by reliable evidence, suitable for the individual and consistent with relevant safety and quality requirements.
Main principles
Correct identification of the health problem.
Selection of a medicine with an appropriate therapeutic purpose.
Use of evidence-based information.
Consideration of patient-specific factors.
Evaluation of potential benefits and harms.
Consideration of contraindications and interactions.
Use of an appropriate formulation and route.
Monitoring of clinical response and safety.
Patient related factors
| Factor | Importance |
|---|---|
Age | Physiological development and age-related changes can influence drug response. |
Body composition | Differences in body composition may affect drug distribution. |
Kidney function | Renal impairment can influence the elimination of certain medicines. |
Liver function | Liver impairment can alter the metabolism of some drugs. |
Pregnancy and lactation | Potential effects on pregnancy, fetal development and breastfeeding must be considered. |
Allergies and previous adverse reactions | Previous reactions may affect the suitability of a medicine. |
Genetic variation | Some genetic differences can influence drug metabolism, transport or response. |
Concurrent medicines | Drug interactions can modify effects, exposure or safety. |
Patient preferences and circumstances | Acceptability, affordability, accessibility and ability to follow the treatment plan can influence treatment success. |
Stepwise rational selection framework
| Step | Name | Description | Reason |
|---|---|---|---|
1 | Define the clinical problem | Identify the condition, its severity, relevant symptoms and treatment objectives. | A clear clinical problem prevents selection of a medicine that does not address the actual healthcare need. |
2 | Establish whether medicine treatment is needed | Consider whether pharmacological treatment is appropriate or whether non-drug interventions, observation or further assessment may be more suitable. | Not every health problem requires medication. |
3 | Identify suitable medicine options | Review medicines with evidence-supported indications for the condition. | A suitable medicine must have a scientifically justified therapeutic role. |
4 | Compare benefits and risks | Evaluate effectiveness, adverse effects, contraindications, interactions and patient-specific considerations. | The most appropriate medicine is not necessarily the newest or most expensive option. |
5 | Consider quality and access | Evaluate formulation, availability, quality assurance and affordability. | A theoretically suitable medicine may be impractical if it cannot be reliably obtained or used. |
6 | Establish treatment objectives and monitoring | Define how benefit and possible harm will be evaluated. | Treatment requires follow-up to determine whether the intended outcome is being achieved. |
7 | Reassess when necessary | Review treatment response, new evidence, tolerability and changes in the patient's condition. | Medicine selection is an ongoing clinical process rather than a one-time decision. |
WHO model list and national policy
Who model list
The WHO Model List of Essential Medicines is periodically reviewed and provides guidance for countries and health systems.
National adaptation
Local disease prevalence and public health priorities
National treatment guidelines
Healthcare infrastructure
Medicine availability
Regulatory approval
Economic and procurement considerations
Health system benefits
Supports priority-based procurement.
Can improve medicine availability.
Helps standardize treatment policies.
Supports more efficient use of healthcare resources.
Provides a framework for medicine quality and supply planning.
Common problems in irrational drug use
| Problem | Description |
|---|---|
Unnecessary medication | Using medicines when there is no sufficient clinical indication. |
Inappropriate medicine selection | Choosing a medicine that does not match the condition or patient requirements. |
Unnecessary polypharmacy | Using more medicines than clinically necessary, increasing complexity and potential interaction risks. |
Inappropriate antimicrobial use | Using antimicrobial medicines without appropriate indications or evidence-based justification, contributing to antimicrobial resistance. |
Insufficient monitoring | Failing to evaluate whether treatment is effective or causing harmful effects. |
Ignoring patient-specific factors | Failing to consider organ function, allergies, interactions or other clinically relevant characteristics. |
Practical evaluation checklist
Is there a clear clinical indication?
Is the medicine supported by reliable evidence?
Is it appropriate for the patient?
Are contraindications and important interactions considered?
Is the formulation suitable?
Is the product quality assured?
Is it accessible and affordable?
Are treatment outcomes and adverse effects monitored?
Common misconceptions
| Misconception | Correction |
|---|---|
Essential medicines are necessarily the cheapest medicines. | Affordability is important, but selection also considers public health relevance, efficacy, safety, quality and comparative cost-effectiveness. |
A medicine on the WHO Model List is appropriate for every patient. | Essential medicine lists guide population-level policy; individual clinical decisions require patient-specific assessment. |
The newest medicine is always the best choice. | The most appropriate option depends on evidence, clinical suitability, safety, availability and comparative value. |
Rational drug selection concerns only the medicine's price. | It includes clinical need, effectiveness, safety, patient characteristics, quality and practical access. |